Preoperative risk stratification and risk reduction for total joint reconstruction: AAOS exhibit selection

Journal of Bone and Joint Surgery

Volumn 95, Issue 4, 2013, Pages

  Ng, Vincent Y ^a   Lustenberger, David ^a   Hoang, Kimberly ^a   Urchek, Ryan ^a   Beal, Matthew ^a   Calhoun, Jason H ^a   Glassman, Andrew H ^a  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METAL;

ADVERSE OUTCOME; AGE DISTRIBUTION; ALCOHOLISM; ANESTHESIST; ARTHROPLASTY; ARTICLE; BARE METAL STENT; CARDIOLOGIST; CARDIOVASCULAR DISEASE; CORONARY STENT; DIABETES MELLITUS; ELECTIVE SURGERY; EVIDENCE BASED PRACTICE; HEART STRESS; HEMATOLOGIC DISEASE; HIP ARTHROPLASTY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOSUPPRESSIVE TREATMENT; LUNG DISEASE; MALNUTRITION; MEDICAID; MEDICAL ASSESSMENT; MEDICAL SOCIETY; MEDICARE; OBESITY; ORTHOPEDIC SURGEON; PATHOLOGY; PATIENT SATISFACTION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERIPHERAL VASCULAR DISEASE; PERIPROSTHETIC JOINT INFECTION; PRACTICE GUIDELINE; PREOPERATIVE CARE; PRIORITY JOURNAL; PROSPECTIVE PAYMENT; PULMONARY HYPERTENSION; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; RISK REDUCTION; RISK STRATIFICATION; SLEEP DISORDERED BREATHING; SMOKING; STANDARDIZATION; THROMBOSIS; TOTAL HIP PROSTHESIS; VENOUS THROMBOEMBOLISM; COMORBIDITY; COST BENEFIT ANALYSIS; ECONOMICS; KNEE ARTHROPLASTY; POSTOPERATIVE COMPLICATION; PREDICTIVE VALUE; PREOPERATIVE PERIOD; REVIEW; RISK FACTOR; UNITED STATES;

ARTHROPLASTY, REPLACEMENT, HIP; ARTHROPLASTY, REPLACEMENT, KNEE; COMORBIDITY; COST-BENEFIT ANALYSIS; HUMANS; POSTOPERATIVE COMPLICATIONS; PREDICTIVE VALUE OF TESTS; PREOPERATIVE PERIOD; RISK ASSESSMENT; RISK FACTORS; UNITED STATES;

MLCS; MLOWN;

EID: 84877929689     PISSN: 00219355     EISSN: 15351386     Source Type: Journal    
DOI: 10.2106/JBJS.L.00603     Document Type: Article

References (276)

1. Kurtz S, Ong K, Lau E, Mowat F, HalpernM. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am. 2007 Apr;89 (4):780-5.
2. Lawrence T, Gudipati S. Assessing patient satisfaction after replacement arthroplasty. J Bone Joint Surg Br. 2010;92-B (Supp IV):496.
3. Bourne RB, Chesworth BM, Davis AM, Mahomed NN, Charron KD. Patient satisfaction after total knee arthroplasty: who is satisfied and who is not? Clin Orthop Relat Res. 2010 Jan;468 (1):57-63.
4. Bourne RB, Chesworth B, Davis A, Mahomed N, Charron K. Comparing patient outcomes after THA and TKA: is there a difference? Clin Orthop Relat Res. 2010 Feb;468 (2):542-6. Epub 2009 Sep 4.
5. Sharrock NE, Cazan MG, Hargett MJ, Williams-Russo P, Wilson PD Jr. Changes in mortality after total hip and knee arthroplasty over a ten-year period. Anesth Analg. 1995 Feb;80 (2):242-8.
6. Pellegrini VD Jr, Sharrock NE, Paiement GD, Morris R, Warwick DJ. Venous thromboembolic disease after total hip and knee arthroplasty: current perspectives in a regulated environment. Instr Course Lect. 2008;57:637-61.
7. Memtsoudis SG, Ma Y, Chiu YL, Walz JM, Voswinckel R, Mazumdar M. Perioperative mortality in patients with pulmonary hypertension undergoing major joint replacement. Anesth Analg. 2010 Nov;111 (5):1110-6. Epub 2010 Sep 14.
8. Mantilla CB, Horlocker TT, Schroeder DR, Berry DJ, Brown DL. Frequency of myocardial infarction, pulmonary embolism, deep venous thrombosis, and death following primary hip or knee arthroplasty. Anesthesiology. 2002 May;96 (5):1140-6.
9. Parvizi J, Mui A, Purtill JJ, Sharkey PF, Hozack WJ, Rothman RH. Total joint arthroplasty: When do fatal or near-fatal complications occur? J Bone Joint Surg Am. 2007 Jan;89 (1):27-32.
10. Huddleston JI, Maloney WJ, Wang Y, Verzier N, Hunt DR, Herndon JH. Adverse events after total knee arthroplasty: a national Medicare study. J Arthroplasty. 2009 Sep;24 (6 Suppl):95-100. Epub 2009 Jul 4.
11. Krishnan E, Fries JF, Kwoh CK. Primary knee and hip arthroplasty among nonagenarians and centenarians in the United States. Arthritis Rheum. 2007 Aug 15;57 (6):1038-42.
12. Lie SA, Pratt N, Ryan P, Engesaeter LB, Havelin LI, Furnes O, Graves S. Duration of the increase in early postoperative mortality after elective hip and knee replacement. J Bone Joint Surg Am. 2010 Jan;92 (1):58-63.
13. Aynardi M, Pulido L, Parvizi J, Sharkey PF, Rothman RH. Early mortality after modern total hip arthroplasty. Clin Orthop Relat Res. 2009 Jan;467 (1):213-8. Epub 2008 Oct 10.
14. Gill GS, Mills D, Joshi AB. Mortality following primary total knee arthroplasty. J Bone Joint Surg Am. 2003 Mar;85-A (3):432-5.
15. Dearborn JT, Harris WH. Postoperative mortality after total hip arthroplasty. An analysis of deaths after two thousand seven hundred and thirty-six procedures. J Bone Joint Surg Am. 1998 Sep;80 (9):1291-4.
16. Lavernia CJ, Guzman JF. Relationship of surgical volume to short-term mortality, morbidity, and hospital charges in arthroplasty. J Arthroplasty. 1995 Apr;10 (2):133-40.
17. Taylor HD, Dennis DA, Crane HS. Relationship between mortality rates and hospital patient volume for Medicare patients undergoing major orthopaedic surgery of the hip, knee, spine, and femur. J Arthroplasty. 1997 Apr;12 (3):235-42.
18. Ritter M, Mamlin LA, Melfi CA, Katz BP, Freund DA, Arthur DS. Outcome implications for the timing of bilateral total knee arthroplasties. Clin Orthop Relat Res. 1997 Dec; (345):99-105.
19. Parvizi J, Sullivan TA, Trousdale RT, Lewallen DG. Thirty-day mortality after total knee arthroplasty. J Bone Joint Surg Am. 2001 Aug;83-A (8):1157-61.
20. Scott WN, Booth RE Jr, Dalury DF, Healy WL, Lonner JH. Efficiency and economics in joint arthroplasty. J Bone Joint Surg Am. 2009 Aug;91 Suppl 5:33-6.
21. Han L, Brown D. Summary of Technical Expert Panel (TEP) Evaluation of Measures. 30-day risk-standardized readmission rate following elective total hip and total knee arthroplasty and risk-standardized complication rate following elective total hip and total knee arthroplasty. 2010 Jul 19. http://www.cch-quality.com/Files/CMS-Hip.Knee-SummaryReport-TEP-7-19-10-FINAL- Hip.TKA.pdf. Accessed 2012 Oct 2.
22. Schwarzkopf R, Katz G, Walsh M, Lafferty PM, Slover JD. Medical clearance risk rating as a predictor of perioperative complications after total hip arthroplasty. J Arthroplasty. 2011 Jan;26 (1):36-40. Epub 2010 May 8.
23. Michel JP, Klopfenstein C, Hoffmeyer P, Stern R, Grab B. Hip fracture surgery: is the pre-operative American Society of Anesthesiologists (ASA) score a predictor of functional outcome? Aging Clin Exp Res. 2002 Oct;14 (5):389-94.
24. Jacqueline R, Malviya S, Burke C, Reynolds P. An assessment of interrater reliability of the ASA physical status classification in pediatric surgical patients. Paediatr Anaesth. 2006 Sep;16 (9):928-31.
25. Wolters U, Wolf T, Stützer H, Schröder T. ASA classification and perioperative variables as predictors of postoperative outcome. Br J Anaesth. 1996 Aug;77 (2):217-22.
26. Clelland C, Worland RL, Jessup DE, East D. Preoperative medical evaluation in patients having joint replacement surgery: added benefits. South Med J. 1996 Oct;89 (10):958-60.
27. Pulido L, Parvizi J, Macgibeny M, Sharkey PF, Purtill JJ, Rothman RH, Hozack WJ. In hospital complications after total joint arthroplasty. J Arthroplasty. 2008 Sep; 23 (6 Suppl 1):139-45.
28. Mortazavi SMJ, Aynardi MC, Jacovides CL, Bican O, Parvizi J, Kirkpatrick K. Risk factors for early mortality following modern uncemented total hip arthroplasty. Presented at the Annual Meeting of the American Academy of Orthopaedic Surgeons; 2011 Feb 15-18; San Diego, CA.
29. Basilico FC, Sweeney G, Losina E, Gaydos J, Skoniecki D, Wright EA, Katz JN. Risk factors for cardiovascular complications following total joint replacement surgery. Arthritis Rheum. 2008 Jul;58 (7):1915-20.
30. Parvizi J, Holiday AD, Ereth MH, Lewallen DG. The Frank Stinchfield Award. Sudden death during primary hip arthroplasty. Clin Orthop Relat Res. 1999 Dec; (369):39-48.
31. Gandhi R, Petruccelli D, Devereaux PJ, Adili A, Hubmann M, de Beer J. Incidence and timing of myocardial infarction after total joint arthroplasty. J Arthroplasty. 2006 Sep;21 (6):874-7.
32. Fleisher LA, Beckman JA, Brown KA, Calkins H, Chaikof EL, Fleischmann KE, Freeman WK, Froehlich JB, Kasper EK, Kersten JR, Riegel B, Robb JF, Smith SC Jr, Jacobs AK, Adams CD, Anderson JL, Antman EM, Buller CE, Creager MA, Ettinger SM, Faxon DP, Fuster V, Halperin JL, Hiratzka LF, Hunt SA, LytleBW, Nishimura R, Ornato JP, Page RL, Riegel B, Tarkington LG, Yancy CW; American College of Cardiology; American Heart Association Task Force on Practice Guidelines (writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery); American Society of Echocardiography; American Society of Nuclear Cardiology; Heart Rhythm Society; Society of Cardiovascular Anesthesiologists; Society for Cardiovascular Angiography and Interventions; Society for VascularMedicine and Biology; Society for Vascular Surgery. ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery) developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for VascularMedicine and Biology, and Society for Vascular Surgery. J Am Coll Cardiol. 2007 Oct 23;50 (17):e159-241.
33. Murphy JT, Fahy BG. Balancing perioperative risks in orthopedic surgery: the patient with a coronary stent. Orthopedics. 2007 Nov;30 (11):931-6; quiz 937-8.
34. Iakovou I, Schmidt T, Bonizzoni E, Ge L, Sangiorgi GM, Stankovic G, Airoldi F, Chieffo A, Montorfano M, Carlino M, Michev I, Corvaja N, Briguori C, Gerckens U, Grube E, Colombo A. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA. 2005 May 4;293 (17): 2126-30.
35. Bono JV, Robbins CE, Talmo CT, Aghazadeh M. Total joint replacement in patients requiring perioperative cardioprotective clopidogrel bisulfate. Presented at the Annual Meeting of the American Academy of Orthopaedic Surgeons; 2011 Feb 15-18; San Diego, CA.
36. Stroke Risk in Atrial Fibrillation Working Group. Independent predictors of stroke in patients with atrial fibrillation: a systematic review. Neurology. 2007 Aug 7;69 (6):546-54.
37. Hajjar I, Kotchen JM, Kotchen TA. Hypertension: trends in prevalence, incidence, and control. Annu Rev Public Health. 2006;27:465-90.
38. Cutler JA, Sorlie PD, Wolz M, Thom T, Fields LE, Roccella EJ. Trends in hypertension prevalence, awareness, treatment, and control rates in United States adults between 1988-1994 and 1999-2004. Hypertension. 2008 Nov;52 (5):818-27. Epub 2008 Oct 13.
39. Hanada S, Kawakami H, Goto T, Morita S. Hypertension and anesthesia. Curr Opin Anaesthesiol. 2006 Jun;19 (3):315-9.
40. Hagen PT, Scholz DG, Edwards WD. Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts. Mayo Clin Proc. 1984 Jan;59 (1):17-20.
41. Sukernik MR, Mets B, Bennett-Guerrero E. Patent foramen ovale and its significance in the perioperative period. Anesth Analg. 2001 Nov;93 (5):1137-46.
42. Homma S, Sacco RL, Di Tullio MR, Sciacca RR, Mohr JP; PFO in Cryptogenic Stroke Study (PICSS) Investigators. Effect of medical treatment in stroke patients with patent foramen ovale: patent foramen ovale in Cryptogenic Stroke Study. Circulation. 2002 Jun 4;105 (22):2625-31.
43. Weiss SJ, Cheung AT, Stecker MM, Garino JP, Hughes JE, Murphy FL. Fatal paradoxical cerebral embolization during bilateral knee arthroplasty. Anesthesiology. 1996 Mar;84 (3):721-3.
44. Masini MA, Stulberg SD. Paradoxical cerebral embolism leading to death after revision total hip arthroplasty. Orthopedics. 1995May;18 (5):484-7; discussion 487-8.
45. Della Valle CJ, Jazrawi LM, Di Cesare PE, Steiger DJ. Paradoxical cerebral embolism complicating a major orthopaedic operation. A report of two cases. J Bone Joint Surg Am. 1999 Jan;81 (1):108-10.
46. Mortazavi SM, Kakli H, Bican O, Moussouttas M, Parvizi J, Rothman RH. Perioperative stroke after total joint arthroplasty: prevalence, predictors, and outcome. J Bone Joint Surg Am. 2010 Sep 1;92 (11):2095-101.
47. Wong GY, Warner DO, Schroeder DR, Offord KP, Warner MA, Maxson PM, Whisnant JP. Risk of surgery and anesthesia for ischemic stroke. Anesthesiology. 2000 Feb;92 (2):425-32.
48. Landercasper J, Merz BJ, Cogbill TH, Strutt PJ, Cochrane RH, Olson RA, Hutter RD. Perioperative stroke risk in 173 consecutive patients with a past history of stroke. Arch Surg. 1990 Aug;125 (8):986-9.
49. lofin I, Levine B, Badlani N, Klein GR, Jaffe WL. Psoriatic arthritis and arthroplasty: a review of the literature. Bull NYU Hosp Jt Dis. 2008;66 (1):41-8.
50. Singh G, Rao DJ. Bacteriology of psoriatic plaques. Dermatologica. 1978;157 (1):21-7.
51. Menon TJ, Wroblewski BM. Charnley low-friction arthroplasty in patients with psoriasis. Clin Orthop Relat Res. 1983 Jun; (176):127-8.
52. Stern SH, Insall JN, Windsor RE, Inglis AE, Dines DM. Total knee arthroplasty in patients with psoriasis. Clin Orthop Relat Res. 1989 Nov; (248):108-10; discussion 111.
53. Beyer CA, Hanssen AD, Lewallen DG, Pittelkow MR. Primary total knee arthroplasty in patients with psoriasis. J Bone Joint Surg Br. 1991 Mar;73 (2):258-9.
54. Kimball AB, Gladman D, Gelfand JM, Gordon K, Horn EJ, Korman NJ, Korver G, Krueger GG, Strober BE, Lebwohl MG; National Psoriasis Foundation. National Psoriasis Foundation clinical consensus on psoriasis comorbidities and recommendations for screening. J Am Acad Dermatol. 2008 Jun;58 (6):1031-42. Epub 2008 Mar 4.
55. Cordero-Ampuero J, de Dios M. What are the risk factors for infection in hemiarthroplasties and total hip arthroplasties? Clin Orthop Relat Res. 2010 Dec;468 (12):3268-77.
56. Luessenhop CP, Higgins LD, Brause BD, Ranawat CS. Multiple prosthetic infections after total joint arthroplasty. Risk factor analysis. J Arthroplasty. 1996 Oct;11 (7):862-8.
57. Bongartz T, Halligan CS, Osmon DR, Reinalda MS, Bamlet WR, Crowson CS, Hanssen AD, Matteson EL. Incidence and risk factors of prosthetic joint infection after total hip or knee replacement in patients with rheumatoid arthritis. Arthritis Rheum. 2008 Dec 15;59 (12):1713-20.
58. Berbari EF, Hanssen AD, Duffy MC, Steckelberg JM, Ilstrup DM, Harmsen WS, Osmon DR. Risk factors for prosthetic joint infection: case-control study. Clin Infect Dis. 1998 Nov;27 (5):1247-54.
59. Eskelinen A, Paavolainen P, Helenius I, Pulkkinen P, Remes V. Total hip arthroplasty for rheumatoid arthritis in younger patients: 2, 557 replacements in the Finnish Arthroplasty Register followed for 0-24 years. Acta Orthop. 2006 Dec;77 (6):853-65.
60. Lai K, Bohm ER, Burnell C, Hedden DR. Presence of medical comorbidities in patients with infected primary hip or knee arthroplasties. J Arthroplasty. 2007 Aug;22 (5):651-6.
61. Wroblewski BM, Siney PD, Fleming PA. Charnley low-frictional torque arthroplasty in young rheumatoid and juvenile rheumatoid arthritis: 292 hips followed for an average of 15 years. Acta Orthop. 2007 Apr;78 (2):206-10.
62. Kaneko A, Eto Y, Tsukamoto M. Survival after total joint arthroplasty in patients with rheumatoid arthritis. Comparison of the postoperative life expectancies and survival by initial operative years: 1970s and 1980s group versus 1990s group. Mod Rheumatol. 2004;14 (6):466-49.
63. Howe CR, Gardner GC, Kadel NJ. Perioperative medication management for the patient with rheumatoid arthritis. J Am Acad Orthop Surg. 2006 Sep;14 (9):544-51.
64. Collins DN, Barnes CL, FitzRandolph RL. Cervical spine instability in rheumatoid patients having total hip or knee arthroplasty. Clin Orthop Relat Res. 1991 Nov; (272):127-35.
65. Kim DH, Hilibrand AS. Rheumatoid arthritis in the cervical spine. J Am Acad Orthop Surg. 2005 Nov;13 (7):463-74.
66. Domsic RT, Lingala B, Krishnan E. Systemic lupus erythematosus, rheumatoid arthritis, and postarthroplastymortality: a cross-sectional analysis fromthe nationwide inpatient sample. J Rheumatol. 2010 Jul;37 (7):1467-72. Epub 2010 May 15.
67. Hanssen AD, Cabanela ME, Michet CJ Jr. Hip arthroplasty in patients with systemic lupus erythematosus. J Bone Joint Surg Am. 1987 Jul;69 (6):807-14.
68. Linares L, Cofán F, Cervera C, Ricart MJ, Oppenheimer F, Campistol JM, Moreno A. Infection-related mortality in a large cohort of renal transplant recipients. Transplant Proc. 2007 Sep;39 (7):2225-7.
69. McCleery MA, Leach WJ, Norwood T. Rates of infection and revision in patients with renal disease undergoing total knee replacement in Scotland. J Bone Joint Surg Br. 2010 Nov;92 (11):1535-9.
70. Nowicki P, Chaudhary H. Total hip replacement in renal transplant patients. J Bone Joint Surg Br. 2007 Dec;89 (12):1561-6.
71. Sayed-Noor AS. Joint Arthroplasties other than the Hip in Solid Organ Transplant Recipients. Open Orthop J. 2009 May 15;3:27-31.
72. Craven DE, Rixinger AI, Goularte TA, McCabe WR. Methicillin-resistant Staphylococcus aureus bacteremia linked to intravenous drug abusers using a ''shooting gallery''. Am J Med. 1986 May;80 (5):770-6.
73. Webb BG, Lichtman DM, Wagner RA. Risk factors in total joint arthroplasty: comparison of infection rates in patients with different socioeconomic backgrounds. Orthopedics. 2008 May;31 (5):445.
74. Lehman CR, Ries MD, Paiement GD, Davidson AB. Infection after total joint arthroplasty in patients with human immunodeficiency virus or intravenous drug use. J Arthroplasty. 2001 Apr;16 (3):330-5.
75. Habermann B, Eberhardt C, Kurth AA. Total joint replacement in HIV positive patients. J Infect. 2008 Jul;57 (1):41-6. Epub 2008 Mar 11.
76. Tønnesen H, Petersen KR, Højgaard L, Stokholm KH, Nielsen HJ, Knigge U, Kehlet H. Postoperative morbidity among symptom-free alcohol misusers. Lancet. 1992 Aug 8;340 (8815):334-7.
77. Felding C, Jensen LM, Tønnesen H. Influence of alcohol intake on postoperative morbidity after hysterectomy. Am J Obstet Gynecol. 1992 Feb;166 (2):667-70.
78. Williams-Russo P, Urquhart BL, Sharrock NE, Charlson ME. Post-operative delirium: predictors and prognosis in elderly orthopedic patients. J Am Geriatr Soc. 1992 Aug;40 (8):759-67.
79. Paterno SA, Lachiewicz PF, Kelley SS. The influence of patient-related factors and the position of the acetabular component on the rate of dislocation after total hip replacement. J Bone Joint Surg Am. 1997 Aug;79 (8):1202-10.
80. Jolles BM, Zangger P, Leyvraz PF. Factors predisposing to dislocation after primary total hip arthroplasty: a multivariate analysis. J Arthroplasty. 2002 Apr;17 (3):282-8.
81. Bozic K, Patel J. Early complications after total hip arthroplasty. Eur Musculoskel Rev. 2009;4 (1):55-7.
82. Ewing JA. Detecting alcoholism. The CAGE questionnaire. JAMA. 1984 Oct 12;252 (14):1905-7.
83. Harris AH, Reeder R, Ellerbe L, Bradley KA, Rubinsky AD, Giori NJ. Preoperative alcohol screening scores: association with complications in men undergoing total joint arthroplasty. J Bone Joint Surg Am. 2011 Feb 16;93 (4):321-7.
84. Tonnesen H, Rosenberg J, Nielsen HJ, Rasmussen V, Hauge C, Pedersen IK, Kehlet H. Effect of preoperative abstinence on poor postoperative outcome in alcohol misusers: randomised controlled trial. BMJ. 1999 May 15;318 (7194):1311-6.
85. Shourie S, Conigrave KM, Proude EM, Ward JE, Wutzke SE, Haber PS. The effectiveness of a tailored intervention for excessive alcohol consumption prior to elective surgery. Alcohol Alcohol. 2006 Nov-Dec;41 (6):643-9. Epub 2006 Aug 10.
86. Hart W, Griffin S, Warren R, Jones R. Dental inspection is important before joint replacement: viridans infection of joints. J Bone Joint Surg Br. 2005;87-B (Suppl 1):46.
87. Moholkar K, Corrigan J. An assessment of the effectiveness of a pre-operative dental visit: an audit of the elective orthopaedic assessment clinic in relation to dental infection and joint arthroplasty. Eur J Orthop Surg Traumatol. 2004;14 (2):75-9.
88. Barrington JW, Barrington T. What is the true incidence of dental pathology in the total joint arthroplasty population? Presented at the Annual Meeting of the American Academy of Orthopaedic Surgeons; 2011 Feb 15-18; San Diego, CA.
89. Ucxkay I, Pittet D, Bernard L, Lew D, Perrier A, Peter R. Antibiotic prophylaxis before invasive dental procedures in patients with arthroplasties of the hip and knee. J Bone Joint Surg Br. 2008 Jul;90 (7):833-8.
90. ADA, AAOS. Advisory statement: antibiotic prophylaxis for dental patients with total joint replacements. 2003. http://orthodoc.aaos.org/WinchesterOrtho/ AAOS-On-Line-Antib.html. Accessed 2012 Oct 2.
91. Little JW, Jacobson JJ, Lockhart PB; American Academy of Oral Medicine. The dental treatment of patients with joint replacements: a position paper from the American Academy of Oral Medicine. J Am Dent Assoc. 2010 Jun;141 (6):667-71.
92. Bartzokas CA, Johnson R, Jane M, Martin MV, Pearce PK, Saw Y. Relation between mouth and haematogenous infection in total joint replacements. BMJ. 1994 Aug 20-27;309 (6953):506-8.
93. Kaar TK, Bogoch ER, Devlin HR. Acute metastatic infection of a revision total hip arthroplasty with oral bacteria after noninvasive dental treatment. J Arthroplasty. 2000 Aug;15 (5):675-8.
94. LaPorte DM, Waldman BJ, Mont MA, Hungerford DS. Infections associated with dental procedures in total hip arthroplasty. J Bone Joint Surg Br. 1999 Jan;81 (1):56-9.
95. Waldman BJ, Mont MA, Hungerford DS. Total knee arthroplasty infections associated with dental procedures. Clin Orthop Relat Res. 1997 Oct; (343):164-72.
96. Samson AJ, Mercer GE, Campbell DG. Total knee replacement in the morbidly obese: a literature review. ANZ J Surg. 2010 Sep;80 (9):595-9. doi: 10.1111/j.1445-2197.2010.05396.x. Epub 2010 Aug 19.
97. Jain NB, Guller U, Pietrobon R, Bond TK, Higgins LD. Comorbidities increase complication rates in patients having arthroplasty. Clin Orthop Relat Res. 2005 Jun; (435):232-8.
98. Guss D, Bhattacharyya T. Perioperative management of the obese orthopaedic patient. J Am Acad Orthop Surg. 2006 Jul;14 (7):425-32.
99. Namba RS, Paxton L, Fithian DC, Stone ML. Obesity and perioperative morbidity in total hip and total knee arthroplasty patients. J Arthroplasty. 2005 Oct;20 (7 Suppl 3):46-50.
100. Batsis JA, Naessens JM, Keegan MT, Huddleston PM, Wagie AE, Huddleston JM. Body mass index and the impact on hospital resource use in patients undergoing total knee arthroplasty. J Arthroplasty. 2010 Dec;25 (8):1250-7.e1. Epub 2010 Feb 19.
101. Lübbeke A, Stern R, Garavaglia G, Zurcher L, Hoffmeyer P. Differences in outcomes of obese women and men undergoing primary total hip arthroplasty. Arthritis Rheum. 2007 Mar 15;57 (2):327-34.
102. Malinzak RA, Ritter MA, Berend ME, Meding JB, Olberding EM, Davis KE. Morbidly obese, diabetic, younger, and unilateral joint arthroplasty patients have elevated total joint arthroplasty infection rates. J Arthroplasty. 2009 Sep;24 (6 Suppl):84-8. Epub 2009 Jul 15.
103. Winiarsky R, Barth P, Lotke P. Total knee arthroplasty in morbidly obese patients. J Bone Joint Surg Am. 1998 Dec;80 (12):1770-4.
104. Giurea A, Holinka J, Jenny J, et al. A multi-centre study including 385 navigated total knee replacements. J Bone Joint Surg Br. 2010;92-B (Suppl IV):536.
105. Dowsey MM, Choong PF. Obese diabetic patients are at substantial risk for deep infection after primary TKA. Clin Orthop Relat Res. 2009 Jun;467 (6):1577-81. Epub 2008 Oct 8.
106. Booth RE Jr. Total knee arthroplasty in the obese patient: tips and quips. J Arthroplasty. 2002 Jun;17 (4 Suppl 1):69-70.
107. Christensen CP, Jacobs C. Morbidly obese TKA patients require lengthier operative procedure and hospital stay. J Arthroplasty. 2009;24 (2):e69.
108. Patel VP, Walsh M, Sehgal B, Preston C, DeWal H, Di Cesare PE. Factors associated with prolonged wound drainage after primary total hip and knee arthroplasty. J Bone Joint Surg Am. 2007 Jan;89 (1):33-8.
109. Callanan MC, Jarrett B, Bragdon CR, Zurakowski D, Rubash HE, Freiberg AA, Malchau H. The John Charnley Award: risk factors for cup malpositioning: quality improvement through a joint registry at a tertiary hospital. Clin Orthop Relat Res. 2011 Feb;469 (2):319-29.
110. Kulkarni A, Jameson SS, James P, Woodcock S, Muller S, Reed MR. Does bariatric surgery prior to lower limb joint replacement reduce complications? Surgeon. 2011 Feb;9 (1):18-21. Epub 2010 Sep 27.
111. Järvenpää J, Kettunen J, Kröger H, Miettinen H. Obesity may impair the early outcome of total knee arthroplasty. Scand J Surg. 2010;99 (1):45-9.
112. SM Rapp. Growing U.S. obesity problem presents opportunities to improve outcomes and change lives. Orthopedic Today. 2010 Aug. http://www.healio.com/ orthopedics/arthritis/news/print/orthopedics-today/%7BF4F21239-5271-494D- 9B91-27B550DAD572%7D/Growing-US-obesity-problem-presents-opportunities- toimprove- outcomes-and-change-lives. Accessed 2012 Oct 2.
113. Polga D, Altenburg A, Trousdale R, Lewallen D. Complications following total hip arthroplasty in the superobese, BMI>50. Presented at the annual meeting of the American Academy of Orthopaedic Surgeons; 2009; Las Vegas, NV.
114. Søballe K, Christensen F, Luxhøj T. Hip replacement in obese patients. Acta Orthop Scand. 1987 Jun;58 (3):223-5.
115. McLaughlin JR, Lee KR. The outcome of total hip replacement in obese and nonobese patients at 10- to 18-years. J Bone Joint Surg Br. 2006 Oct;88 (10):1286-92.
116. Andrew JG, Palan J, Kurup HV, Gibson P, Murray DW, Beard DJ. Obesity in total hip replacement. J Bone Joint Surg Br. 2008 Apr;90 (4):424-9.
117. Ibrahim T, Hobson S, Beiri A, Esler CN. No influence of body mass index on early outcome following total hip arthroplasty. Int Orthop. 2005 Dec;29 (6):359-61. Epub 2005 Sep 24.
118. Jiganti JJ, Goldstein WM, Williams CS. A comparison of the perioperative morbidity in total joint arthroplasty in the obese and nonobese patient. Clin Orthop Relat Res. 1993 Apr; (289):175-9.
119. Stickles B, Phillips L, Brox WT, Owens B, Lanzer WL. Defining the relationship between obesity and total joint arthroplasty. Obes Res. 2001 Mar;9 (3):219-23.
120. Amin AK, Clayton RA, Patton JT, Gaston M, Cook RE, Brenkel IJ. Total knee replacement in morbidly obese patients. Results of a prospective, matched study. J Bone Joint Surg Br. 2006 Oct;88 (10):1321-6.
121. Röder C, Bach B, Berry DJ, Eggli S, Langenhahn R, Busato A. Obesity, age, sex, diagnosis, and fixation mode differently affect early cup failure in total hip arthroplasty: a matched case-control study of 4420 patients. J Bone Joint Surg Am. 2010 Aug 18;92 (10):1954-63.
122. Leff DR, Heath D. Surgery for obesity in adulthood. BMJ. 2009 Sep 22;339: b3402. doi: 10.1136/bmj.b3402.
123. Maggard MA, Shugarman LR, Suttorp M, MaglioneM, Sugerman HJ, Livingston EH, Nguyen NT, Li Z, Mojica WA, Hilton L, Rhodes S, Morton SC, Shekelle PG. Metaanalysis: surgical treatment of obesity. Ann Intern Med. 2005 Apr 5;142 (7):547-59.
124. Abu-Abeid S, Wishnitzer N, Szold A, Liebergall M, Manor O. The influence of surgically-induced weight loss on the knee joint. Obes Surg. 2005 Nov-Dec;15 (10): 1437-42.
125. Severson EP, Browne JA, Singh J, Trousdale RT, Lewallen DG. Total knee arthroplasty in morbidly obese patients treated with bariatric surgery: a comparative study. Presented at the Annual Meeting of the American Academy of Orthopaedic Surgeons; 2011 Feb 15-18; San Diego, CA.
126. Berend KR, Ajluni AF, N'uñez-Garciá LA, Lombardi AV, Adams JB. Prevalence and management of obstructive sleep apnea in patients undergoing total joint arthroplasty. J Arthroplasty. 2010 Sep;25 (6 Suppl):54-7. Epub 2010 Jun 26.
127. Bixler EO, Vgontzas AN, Ten Have T, Tyson K, Kales A. Effects of age on sleep apnea in men: I. Prevalence and severity. Am J Respir Crit Care Med. 1998 Jan; 157 (1):144-8.
128. Durán J, Esnaola S, Rubio R, Iztueta A. Obstructive sleep apnea-hypopnea and related clinical features in a population-based sample of subjects aged 30 to 70 yr. Am J Respir Crit Care Med. 2001 Mar;163 (3 Pt 1):685-9.
129. Chung SA, Yuan H, Chung F. A systemic review of obstructive sleep apnea and its implications for anesthesiologists. Anesth Analg. 2008 Nov;107 (5):1543-63.
130. Practice parameters for the indications for polysomnography and related procedures. Polysomnography Task Force, American Sleep Disorders Association Standards of Practice Committee. Sleep. 1997 Jun;20 (6):406-22.
131. Gross JB, Bachenberg KL, Benumof JL, Caplan RA, Connis RT, Coté CJ, Nickinovich DG, Prachand V, Ward DS, Weaver EM, Ydens L, Yu S; American Society of Anesthesiologists Task Force on Perioperative Management. Practice guidelines for the perioperative management of patients with obstructive sleep apnea: a report by the American Society of Anesthesiologists Task Force on Perioperative Management of patients with obstructive sleep apnea. Anesthesiology. 2006 May;104 (5): 1081-93; quiz 1117-8.
132. Coventry MB, Beckenbaugh RD, Nolan DR, Ilstrup DM. 2, 012 total hip arthroplasties. A study of postoperative course and early complications. J Bone Joint Surg Am. 1974 Mar;56 (2):273-84.
133. Howie C, Hughes H, Watts AC. Venous thromboembolism associated with hip and knee replacement over a ten-year period: a population-based study. J Bone Joint Surg Br. 2005 Dec;87 (12):1675-80.
134. SooHoo NF, Lieberman JR, Ko CY, Zingmond DS. Factors predicting complication rates following total knee replacement. J Bone Joint Surg Am. 2006 Mar; 88 (3):480-5.
135. Eikelboom J, Hirsh J. Deep vein thrombosis prophylaxis: response. Chest. 2009;136 (6):1700-1.
136. Eikelboom JW, Karthikeyan G, Fagel N, Hirsh J. American Association of Orthopedic Surgeons and American College of Chest Physicians guidelines for venous thromboembolism prevention in hip and knee arthroplasty differ: what are the implications for clinicians and patients? Chest. 2009 Feb;135 (2):513-20.
137. Eikelboom JW, Quinlan DJ, Douketis JD. Extended-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a metaanalysis of the randomised trials. Lancet. 2001 Jul 7;358 (9275):9-15.
138. Guyatt GH, Cook DJ, Jaeschke R, Pauker SG, Schünemann HJ. Grades of recommendation for antithrombotic agents: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008 Jun;133 (6 Suppl):123S-131S.
139. Johanson NA, Lachiewicz PF, Lieberman JR, Lotke PA, Parvizi J, Pellegrini V, Stringer TA, Tornetta P 3rd, Haralson RH 3rd, Watters WC 3rd. Prevention of symptomatic pulmonary embolism in patients undergoing total hip or knee arthroplasty. J Am Acad Orthop Surg. 2009 Mar;17 (3):183-96.
140. Weber KL, Zuckerman JD, Watters WC 3rd, Turkelson CM. Deep vein thrombosis prophylaxis. Chest. 2009 Dec;136 (6):1699-700; author reply 1700-1.
141. Lombardi AJ, Ng VY. DVT prophylaxis following unicompartmental knee arthroplasty. In: Berend KR, Cushner F, editors. Partial knee arthroplasty: a primer for the partial knee arthroplasty surgeon. Philadelphia: Saunders; 2011. p 233-40.
142. Lachiewicz PF, Lieberman JR, Lotke PA, Parvizi J, Pellegrini V, Stringer TA, Tornetta P III, Watters WC III. Clinical guideline: prevention of pulmonary embolism in patients undergoing total hip or knee arthroplasty. J Am Acad Orthop Surg. 2009;17:183-96.
143. Bass AR, Mattern CJ, Voos JE, Peterson MG, Trost DW. Inferior vena cava filter placement in orthopedic surgery. AmJ Orthop (Belle Mead NJ). 2010 Sep;39 (9):435-9.
144. Emerson RH Jr, Cross R, Head WC. Prophylactic and early therapeutic use of the Greenfield filter in hip and knee joint arthroplasty. J Arthroplasty. 1991 Jun;6 (2):129-35.
145. Golueke PJ, Garrett WV, Thompson JE, Smith BL, Talkington CM. Interruption of the vena cava by means of the Greenfield filter: expanding the indications. Surgery. 1988 Jan;103 (1):111-7.
146. Vaughn BK, Knezevich S, Lombardi AV Jr, Mallory TH. Use of the Greenfield filter to prevent fatal pulmonary embolism associated with total hip and knee arthroplasty. J Bone Joint Surg Am. 1989 Dec;71 (10):1542-8.
147. PREPIC Study Group. Eight-year follow-up of patients with permanent vena cava filters in the prevention of pulmonary embolism: the PREPIC (Prevention du Risque d'Embolie Pulmonaire par Interruption Cave) randomized study. Circulation. 2005 Jul 19;112 (3):416-22. Epub 2005 Jul 11.
148. Decousus H, Leizorovicz A, Parent F, Page Y, Tardy B, Girard P, Laporte S, Faivre R, Charbonnier B, Barral FG, Huet Y, Simonneau G. A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. Prévention du Risque d'Embolie Pulmonaire par Interruption Cave Study Group. N Engl J Med. 1998 Feb 12;338 (7):409-15.
149. Gorman PH, Qadri SF, Rao-Patel A. Prophylactic inferior vena cava (IVC) filter placement may increase the relative risk of deep venous thrombosis after acute spinal cord injury. J Trauma. 2009 Mar;66 (3):707-12.
150. Strauss EJ, Egol KA, Alaia M, Hansen D, Bashar M, Steiger D. The use of retrievable inferior vena cava filters in orthopaedic patients. J Bone Joint Surg Br. 2008 May;90 (5):662-7.
151. Beutler E, Waalen J. The definition of anemia: what is the lower limit of normal of the blood hemoglobin concentration? Blood. 2006 Mar 1;107 (5):1747-50. Epub 2005 Sep 27.
152. Guralnik JM, Ershler WB, Schrier SL, Picozzi VJ. Anemia in the elderly: a public health crisis in hematology. Hematology Am Soc Hematol Educ Program. 2005:528-32.
153. Goodnough LT, Vizmeg K, Sobecks R, Schwarz A, SoegiarsoW. Prevalence and classification of anemia in elective orthopedic surgery patients: implications for blood conservation programs. Vox Sang. 1992;63 (2):90-5.
154. Salido JA, Marín LA, Gómez LA, Zorrilla P, Martínez C. Preoperative hemoglobin levels and the need for transfusion after prosthetic hip and knee surgery: analysis of predictive factors. J Bone Joint Surg Am. 2002 Feb;84-A (2):216-20.
155. Hatzidakis AM, Mendlick RM, McKillip T, Reddy RL, Garvin KL. Preoperative autologous donation for total joint arthroplasty. An analysis of risk factors for allogenic transfusion. J Bone Joint Surg Am. 2000 Jan;82 (1):89-100.
156. Forgie MA, Wells PS, Laupacis A, Fergusson D. Preoperative autologous donation decreases allogeneic transfusion but increases exposure to all red blood cell transfusion: results of a meta-analysis. International Study of Perioperative Transfusion (ISPOT) Investigators. Arch Intern Med. 1998 Mar 23;158 (6):610-6.
157. Jackson D, Colwell CJ, Della Valle C, Kwong L, Steele M. Tips and pearls:
158. Boettner F, Altneu EI, Williams BA, Hepinstall M, Sculco TP. Nonanemic patients do not benefit from autologous blood donation before total hip replacement. HSS J. 2010 Feb;6 (1):66-70. Epub 2009 Dec 5.
159. Bierbaum BE, Callaghan JJ, Galante JO, Rubash HE, Tooms RE, Welch RB. An analysis of blood management in patients having a total hip or knee arthroplasty. J Bone Joint Surg Am. 1999 Jan;81 (1):2-10.
160. Mantilla CB, Wass CT, Goodrich KA, Johanns CJ, Kool ML, Zhu X, Corredor JA, Warner DO, Joyner MJ, Berry DJ, Schroeder DR, Sprung J. Risk for perioperative myocardial infarction and mortality in patients undergoing hip or knee arthroplasty: the role of anemia. Transfusion. 2011 Jan;51 (1):82-91. doi: 10.1111/j.1537- 2995.2010.02797.x.
161. Rodriguez-Merchan EC. Total knee replacement in haemophilic arthropathy. J Bone Joint Surg Br. 2007 Feb;89 (2):186-8.
162. Powell DL, Whitener CJ, Dye CE, Ballard JO, Shaffer ML, Eyster ME. Knee and hip arthroplasty infection rates in persons with haemophilia: a 27 year single center experience during the HIV epidemic. Haemophilia. 2005 May;11 (3):233-9.
163. Silva M, Luck JV Jr. Long-term results of primary total knee replacement in patients with hemophilia. J Bone Joint Surg Am. 2005 Jan;87 (1):85-91.
164. Tagariello G, De Biasi E, Gajo GB, Risato R, Radossi P, Davoli PG, Traldi A. Recombinant FVIIa (NovoSeven) continuous infusion and total hip replacement in patients with haemophilia and high titre of inhibitors to FVIII: experience of two cases. Haemophilia. 2000 Sep;6 (5):581-3.
165. Faradji A, Bonnomet F, Lecocq J, Grunebaum L, Desprez D, Kern O, Barbier L, Sibilia J. Knee joint arthroplasty in a patient with haemophilia A and high inhibitor titre using recombinant factor VIIa (NovoSeven): a new case report and review of the literature. Haemophilia. 2001 May;7 (3):321-6.
166. Cohen I, Heim M, Martinowitz U, Chechick A. Orthopaedic outcome of total knee replacement in haemophilia A. Haemophilia. 2000 Mar;6 (2):104-9.
167. Beeton K, Rodriguez-Merchan EC, Alltree J. Total joint arthroplasty in haemophilia. Haemophilia. 2000 Sep;6 (5):474-81.
168. Chiang CC, Chen PQ, Shen MC, Tsai W. Total knee arthroplasty for severe haemophilic arthropathy: long-term experience in Taiwan. Haemophilia. 2008 Jul;14 (4):828-34. Epub 2008 May 22.
169. Bae DK, Yoon KH, Kim HS, Song SJ. Total knee arthroplasty in hemophilic arthropathy of the knee. J Arthroplasty. 2005 Aug;20 (5):664-8.
170. Jeong GK, Ruchelsman DE, Jazrawi LM, Jaffe WL. Total hip arthroplasty in sickle cell hemoglobinopathies. J Am Acad Orthop Surg. 2005 May-Jun;13 (3):208-17.
171. Vichinsky EP, Neumayr LD, Haberkern C, Earles AN, Eckman J, Koshy M, Black DM. The perioperative complication rate of orthopedic surgery in sickle cell disease: report of the National Sickle Cell Surgery Study Group. Am J Hematol. 1999 Nov;62 (3):129-38.
172. Rouvillain JL, Ribeyre D, Ouldamar A, Serra C, Pascal-Moussellard H, Delattre O, Catonne Y. Complications of total hip arthroplasty in patients with sickle-cell anemia related osteonecrosis. J Bone Joint Surg Br. 2008;90-B (Suppl II):288-9.
173. Vichinsky EP, Haberkern CM, Neumayr L, Earles AN, Black D, Koshy M, Pegelow C, Abboud M, Ohene-Frempong K, Iyer RV. A comparison of conservative and aggressive transfusion regimens in the perioperative management of sickle cell disease. The Preoperative Transfusion in Sickle Cell Disease Study Group. N Engl J Med. 1995 Jul 27;333 (4):206-13.
174. Fehring TK, Odum SM, Fehring K, Springer BD, Griffin WL, Dennos AC. Mortality following revision joint arthroplasty: is age a factor? Orthopedics. 2010 Oct 11;33 (10):715. doi: 10.3928/01477447-20100826-03.
175. Memtsoudis SG, Ma Y, Gonzalez Della, Valle A, Besculides MC, Gaber LK, Koulouvaris P, Liu SS. Demographics, outcomes, and risk factors for adverse events associated with primary and revision total hip arthroplasties in the United States. Am J Orthop (Belle Mead NJ). 2010 Aug;39 (8):E72-7.
176. McAlister FA, Khan NA, Straus SE, Papaioakim M, Fisher BW, Majumdar SR, Gajic O, Daniel M, Tomlinson G. Accuracy of the preoperative assessment in predicting pulmonary risk after nonthoracic surgery. Am J Respir Crit Care Med. 2003 Mar 1;167 (5):741-4. Epub 2002 Dec 4.
177. Brander VA, Malhotra S, Jet J, Heinemann AW, Stulberg SD. Outcome of hip and knee arthroplasty in persons aged 80 years and older. Clin Orthop Relat Res. 1997 Dec; (345):67-78.
178. Schoenhofen EA, Wyszynski DF, Andersen S, Pennington J, Young R, Terry DF, Perls TT. Characteristics of 32 supercentenarians. J Am Geriatr Soc. 2006 Aug; 54 (8):1237-40.
179. Jafari SM, Huang R, Joshi A, Parvizi J, Hozack WJ. Renal impairment following total joint arthroplasty: who is at risk? J Arthroplasty. 2010 Sep;25 (6 Suppl):49-53, 53.e1-2. Epub 2010 May 31.
180. Lee TH, Marcantonio ER, Mangione CM, Thomas EJ, Polanczyk CA, Cook EF, Sugarbaker DJ, Donaldson MC, Poss R, Ho KK, Ludwig LE, Pedan A, Goldman L. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation. 1999 Sep 7;100 (10):1043-9.
181. Chertow GM, Lazarus JM, Christiansen CL, Cook EF, Hammermeister KE, Grover F, Daley J. Preoperative renal risk stratification. Circulation. 1997 Feb 18;95 (4):878-84.
182. Shlipak MG, Heidenreich PA, Noguchi H, Chertow GM, Browner WS, McClellan MB. Association of renal insufficiency with treatment and outcomes after myocardial infarction in elderly patients. Ann Intern Med. 2002 Oct 1;137 (7):555-62.
183. Toomey HE, Toomey SD. Hip arthroplasty in chronic dialysis patients. J Arthroplasty. 1998 Sep;13 (6):647-52.
184. Fukunishi S, Fukui T, Nishio S, Imamura F, Yoh K, Yoshiya S. Results of total hip arthroplasty for dialysis arthropathy in long-term hemodialysis patients. J Orthop Sci. 2009 May;14 (3):285-91. Epub 2009 Jun 5.
185. Debarge R, Pibarot V, Guyen O, Vaz G, Carret JP, Bejui-Hugues J. [Total hip arthroplasty in patients with chronic renal failure transplant or dialysis]. Rev Chir Orthop Reparatrice Appar Mot. 2007 May;93 (3):222-7. French.
186. Sakalkale DP, Hozack WJ, Rothman RH. Total hip arthroplasty in patients on long-term renal dialysis. J Arthroplasty. 1999 Aug;14 (5):571-5.
187. Li WC, Shih CH, Ueng SW, Shih HN, Lee MS, Hsieh PH. Uncemented total hip arthroplasty in chronic hemodialysis patients. Acta Orthop. 2010 Apr;81 (2):178-82.
188. Lieberman JR, Fuchs MD, Haas SB, Garvin KL, Goldstock L, Gupta R, Pellicci PM, Salvati EA. Hip arthroplasty in patients with chronic renal failure. J Arthroplasty. 1995 Apr;10 (2):191-5.
189. Naito M, Ogata K, Shiota E, Nakamoto M, Goya T. Hip arthroplasty in haemodialysis patients. J Bone Joint Surg Br. 1994 May;76 (3):428-31.
190. Nagoya S, Nagao M, Takada J, Kuwabara H, Kaya M, Yamashita T. Efficacy of cementless total hip arthroplasty in patients on long-termhemodialysis. J Arthroplasty. 2005 Jan;20 (1):66-71.
191. Shrader MW, Schall D, Parvizi J, McCarthy JT, Lewallen DG. Total hip arthroplasty in patients with renal failure: a comparison between transplant and dialysis patients. J Arthroplasty. 2006 Apr;21 (3):324-9.
192. Abu Dakka M, Badri H, Al-Khaffaf H. Total knee arthroplasty in patients with peripheral vascular disease. Surgeon. 2009 Dec;7 (6):362-5.
193. Da Silva MS, Sobel M; Surgeons of the Southern Association of Vascular Surgery. Popliteal vascular injury during total knee arthroplasty. J Surg Res. 2003 Feb;109 (2):170-4.
194. Smith DE, McGraw RW, Taylor DC, Masri BA. Arterial complications and total knee arthroplasty. J Am Acad Orthop Surg. 2001 Jul-Aug;9 (4):253-7.
195. Hitt K. Prevention and management of neurovascular injuries. Sem Arthroplasty. 2003;14 (4):194-202.
196. Garabekyan T, Oliashirazi A, Winters K. The value of immediate preoperative vascular examination in an at-risk patient for total knee arthroplasty. Orthopedics. 2011 Jan 3;34 (1):52. doi: 10.3928/01477447-20101123- 23.
197. DeLaurentis DA, Levitsky KA, Booth RE, Rothman RH, Calligaro KD, Raviola CA, Savarese RP. Arterial and ischemic aspects of total knee arthroplasty. Am J Surg. 1992 Sep;164 (3):237-40.
198. Patil S, Allan DB, Quin R. Effect of total knee arthroplasty on blood flow to the lower limb: a prospective clinical study and review of literature. J Arthroplasty. 2002 Oct;17 (7):882-6.
199. Bowman NK, Appleyard M, Williams F, Bassilly AA, Lim WF, McKay G, Andrews BT. The effect of total knee arthroplasty on lower limb blood flow. J Arthroplasty. 2011 Feb;26 (2):250-4. Epub 2010 Jun 8.
200. Turner NS 3rd, Pagnano MW, Sim FH. Total knee arthroplasty after ipsilateral peripheral arterial bypass graft: acute arterial occlusion is a risk with or without tourniquet use. J Arthroplasty. 2001 Apr;16 (3):317-21.
201. Matar WY, Jafari SM, Restrepo C, Austin M, Purtill JJ, Parvizi J. Preventing infection in total joint arthroplasty. J Bone Joint Surg Am. 2010 Dec;92 Suppl 2:36-46.
202. Urquhart DM, Hanna FS, Brennan SL, Wluka AE, Leder K, Cameron PA, Graves SE, Cicuttini FM. Incidence and risk factors for deep surgical site infection after primary total hip arthroplasty: a systematic review. J Arthroplasty. 2010 Dec;25 (8):1216-22.e1-3. Epub 2009 Oct 30.
203. Moucha C, Evans R, Clyburn T, Huddleston P, Prokuski L, Joseph J, Sale K. Orthopaedic infection prevention and control: an emerging new paradigm. http://www.aaos.org/research/committee/ptsafety/PS-SE-2009.pdf. Accessed 2012 Oct 2.
204. Horan TC, Culver DH, Gaynes RP, Jarvis WR, Edwards JR, Reid CR. Nosocomial infections in surgical patients in the United States, January 1986-June 1992. National Nosocomial Infections Surveillance (NNIS) System. Infect Control Hosp Epidemiol. 1993 Feb;14 (2):73-80.
205. Lai K, Bohm ER, Burnell C, Hedden DR. Presence of medical comorbidities in patients with infected primary hip or knee arthroplasties. J Arthroplasty. 2007 Aug;22 (5):651-6.
206. Parvizi J, Adeli B, Zmistowski B, Restrepo C, Greenwald AS. Management of periprosthetic joint infection: the current knowledge. Presented at the Annual Meeting of the American Academy of Orthopaedic Surgeons; 2011 Feb 15-18; San Diego, CA.
207. Kim DH, Spencer M, Davidson SM, Li L, Shaw JD, Gulczynski D, Hunter DJ, Martha JF, Miley GB, Parazin SJ, Dejoie P, Richmond JC. Institutional prescreening for detection and eradication of methicillin-resistant Staphylococcus aureus in patients undergoing elective orthopaedic surgery. J Bone Joint Surg Am. 2010 Aug 4;92 (9):1820-6. Epub 2010 Jul 7.
208. Rao N, Cannella B, Crossett LS, Yates AJ Jr, McGough R 3rd. A preoperative decolonization protocol for staphylococcus aureus prevents orthopaedic infections. Clin Orthop Relat Res. 2008 Jun;466 (6):1343-8. Epub 2008 Apr 11.
209. Kim DH, Spencer M, Davidson SM, Li L, Shaw JD, Gulczynski D, Hunter DJ, Martha JF, Miley GB, Parazin SJ, Dejoie P, Richmond JC. Institutional prescreening for detection and eradication of methicillin-resistant Staphylococcus aureus in patients undergoing elective orthopaedic surgery. J Bone Joint Surg Am. 2010 Aug 4;92 (9):1820-6. Epub 2010 Jul 7.
210. Ries MD. Vancomycin-resistant Enterococcus infected total knee arthroplasty. J Arthroplasty. 2001 Sep;16 (6):802-5.
211. Koulouvaris P, Sculco P, Finerty E, Sculco T, Sharrock NE. Relationship between perioperative urinary tract infection and deep infection after joint arthroplasty. Clin Orthop Relat Res. 2009 Jul;467 (7):1859-67. Epub 2008 Nov 14.
212. Martinez-Velez D, Gonzalez-Fernandez E, Cordero-Ampuero J, Casa de Pantoja V. Asymptomatic urinary infection in patients undergoing elective hip and knee arthroplasty. J Bone Joint Surg Br. 2010;92-B (Suppl I):85.
213. Wymenga AB, van Horn JR, Theeuwes A, Muytjens HL, Slooff TJ. Perioperative factors associated with septic arthritis after arthroplasty. Prospectivemulticenter study of 362 knee and 2, 651 hip operations. Acta Orthop Scand. 1992 Dec;63 (6):665-71.
214. D'Ambrosia RD, Shoji H, Heater R. Secondarily infected total joint replacements by hematogenous spread. J Bone Joint Surg Am. 1976 Jun;58 (4):450-3.
215. Michelson JD, Lotke PA, Steinberg ME. Urinary-bladder management after total joint-replacement surgery. N Engl J Med. 1988 Aug 11;319 (6):321-6.
216. Knight RM, Pellegrini VD Jr. Bladder management after total joint arthroplasty. J Arthroplasty. 1996 Dec;11 (8):882-8.
217. Agency for Healthcare Research and Quality. Surgical Care Improvement Project: percent of surgical patients with urinary catheter removed on postoperative day 1 or postoperative day 2 with the day of surgery being day zero. http://www.qualitymeasures.ahrq.gov/content.aspx?id=27416. Accessed 2012 Oct 2.
218. Gould CV, Umscheid CA, Agarwal RK, Kuntz G, Pegues DA; Healthcare Infection Control Practices Advisory Committee. Guideline for prevention of catheterassociated urinary tract infections 2009. Infect Control Hosp Epidemiol. 2010 Apr;31 (4):319-26.
219. Jämsen E, Huhtala H, Puolakka T, Moilanen T. Risk factors for infection after knee arthroplasty. A register-based analysis of 43, 149 cases. J Bone Joint Surg Am. 2009 Jan;91 (1):38-47.
220. Larson AN, Hanssen AD, Cass Jr. Does prior infection alter the outcome of TKA after tibial plateau fracture? Clin Orthop Relat Res. 2009 Jul;467 (7):1793-9. Epub 2008 Nov 12.
221. Suzuki G, Saito S, Ishii T, Motojima S, Tokuhashi Y, Ryu J. Previous fracture surgery is a major risk factor of infection after total knee arthroplasty. Knee Surg Sports Traumatol Arthrosc. 2011 Dec;19 (12):2040-4. Epub 2011 May 4.
222. Christensen CP, Jacobs CA, Jennings HR. Effect of periarticular corticosteroid injections during total knee arthroplasty. A double-blind randomized trial. J Bone Joint Surg Am. 2009 Nov;91 (11):2550-5.
223. Pang HN, Lo NN, Yang KY, Chong HC, Yeo SJ. Peri-articular steroid injection improves the outcome after unicondylar knee replacement: a prospective, randomised controlled trial with a two-year follow-up. J Bone Joint Surg Br. 2008 Jun;90 (6):738-44.
224. Austin L, Pulido L, Ropiak R, Porat M, Parvizi J, Rothman RH. Hypoxemia after total joint arthroplasty: a problem on the rise. J Arthroplasty. 2008 Oct;23 (7):1016-21.
225. Smetana GW. Preoperative pulmonary evaluation. N Engl J Med. 1999 Mar 25;340 (12):937-44.
226. Wightman JA. A prospective survey of the incidence of postoperative pulmonary complications. Br J Surg. 1968 Feb;55 (2):85-91.
227. Pedersen T, Eliasen K, Henriksen E. A prospective study of risk factors and cardiopulmonary complications associated with anaesthesia and surgery: risk indicators of cardiopulmonary morbidity. Acta Anaesthesiol Scand. 1990 Feb; 34 (2):144-55.
228. Tarhan S, Moffitt EA, Sessler AD, Douglas WW, Taylor WF. Risk of anesthesia and surgery in patients with chronic bronchitis and chronic obstructive pulmonary disease. Surgery. 1973 Nov;74 (5):720-6.
229. Licker M, Schweizer A, Ellenberger C, Tschopp JM, Diaper J, Clergue F. Perioperative medical management of patients with COPD. Int J Chron Obstruct Pulmon Dis. 2007;2 (4):493-515.
230. Warner DO, Warner MA, Barnes RD, Offord KP, Schroeder DR, Gray DT, Yunginger JW. Perioperative respiratory complications in patients with asthma. Anesthesiology. 1996 Sep;85 (3):460-7.
231. Guidelines for the diagnosis and management of asthma. National Heart, Lung, and Blood Institute. National Asthma Education Program. Expert Panel Report. J Allergy Clin Immunol. 1991 Sep;88 (3 Pt 2):425-534.
232. Pien LC, Grammer LC, Patterson R. Minimal complications in a surgical population with severe asthma receiving prophylactic corticosteroids. J Allergy Clin Immunol. 1988 Oct;82 (4):696-700.
233. Kabalin CS, Yarnold PR, Grammer LC. Low complication rate of corticosteroidtreated asthmatics undergoing surgical procedures. Arch Intern Med. 1995 Jul 10;155 (13):1379-84.
234. Silvanus MT, Groeben H, Peters J. Corticosteroids and inhaled salbutamol in patients with reversible airway obstruction markedly decrease the incidence of bronchospasm after tracheal intubation. Anesthesiology. 2004 May;100 (5):1052-7.
235. Lai HC, Lai HC, Wang KY, Lee WL, Ting CT, Liu TJ. Severe pulmonary hypertension complicates postoperative outcome of non-cardiac surgery. Br J Anaesth. 2007 Aug;99 (2):184-90. Epub 2007 Jun 18.
236. Ramakrishna G, Sprung J, Ravi BS, Chandrasekaran K, McGoon MD. Impact of pulmonary hypertension on the outcomes of noncardiac surgery: predictors of perioperative morbidity and mortality. J Am Coll Cardiol. 2005 May 17;45 (10):1691-9.
237. Sopori ML, Kozak W. Immunomodulatory effects of cigarette smoke. J Neuroimmunol. 1998 Mar 15;83 (1-2):148-56.
238. Jensen JA, Goodson WH, Hopf HW, Hunt TK. Cigarette smoking decreases tissue oxygen. Arch Surg. 1991 Sep;126 (9):1131-4.
239. Møller AM, Villebro N, Pedersen T, Tønnesen H. Effect of preoperative smoking intervention on postoperative complications: a randomised clinical trial. Lancet. 2002 Jan 12;359 (9301):114-7.
240. Thomsen T, Tønnesen H, Møller AM. Effect of preoperative smoking cessation interventions on postoperative complications and smoking cessation. Br J Surg. 2009 May;96 (5):451-61.
241. Lindström D, Sadr Azodi O, Wladis A, Tønnesen H, Linder S, Nåsell H, Ponzer S, Adami J. Effects of a perioperative smoking cessation intervention on postoperative complications: a randomized trial. Ann Surg. 2008 Nov;248 (5):739-45.
242. Sørensen LT, Jørgensen T. Short-term pre-operative smoking cessation intervention does not affect postoperative complications in colorectal surgery: a randomized clinical trial. Colorectal Dis. 2003 Jul;5 (4):347-52.
243. Warner MA, Divertie MB, Tinker JH. Preoperative cessation of smoking and pulmonary complications in coronary artery bypass patients. Anesthesiology. 1984 Apr;60 (4):380-3.
244. Finnegan M. A preoperative smoking cessation intervention increases postoperative quit rates and may reduce postoperative morbidity. J Bone Joint Surg Am. 2011 Feb 16;93 (4):394.
245. Møller A, Villebro N. Interventions for preoperative smoking cessation. Cochrane Database Syst Rev. 2005 Jul 20; (3):CD002294.
246. Mills E, Eyawo O, Lockhart I, Kelly S, Wu P, Ebbert JO. Smoking cessation reduces postoperative complications: a systematic review and meta-analysis. Am J Med. 2011 Feb;124 (2):144-154.e8.
247. Bolognesi M, Merkel C, Bianco S, Angeli P, Sacerdoti D, Amodio P, Gatta A. Clinical significance of the evaluation of hepatic reticuloendothelial removal capacity in patients with cirrhosis. Hepatology. 1994 Mar;19 (3):628-34.
248. Fiuza C, Salcedo M, Clemente G, Tellado JM. In vivo neutrophil dysfunction in cirrhotic patients with advanced liver disease. J Infect Dis. 2000 Aug;182 (2):526-33. Epub 2000 Jul 24.
249. Child CG, Turcotte JG. Surgery and portal hypertension. Major Probl Clin Surg. 1964;1:1-85.
250. Shih LY, Cheng CY, Chang CH, Hsu KY, HsuRW, Shih HN. Total knee arthroplasty in patients with liver cirrhosis. J Bone Joint Surg Am. 2004 Feb;86-A (2):335-41.
251. Cohen SM, Te HS, Levitsky J. Operative risk of total hip and knee arthroplasty in cirrhotic patients. J Arthroplasty. 2005 Jun;20 (4):460-6.
252. Lavernia CJ, Sierra RJ, Baerga L. Nutritional parameters and short term outcome in arthroplasty. J Am Coll Nutr. 1999 Jun;18 (3):274-8.
253. Austin M, Hansen PL, Brothers J. Infection in revision total joint arthroplasty (TJA): the role of nutrition screening. Presented at the Annual Meeting of the American Academy of Orthopaedic Surgeons; 2011 Feb 15-18; San Diego, CA.
254. Greene KA, Wilde AH, Stulberg BN. Preoperative nutritional status of total joint patients. Relationship to postoperative wound complications. J Arthroplasty. 1991 Dec;6 (4):321-5.
255. Jaberi FM, Parvizi J, Haytmanek CT, Joshi A, Purtill J. Procrastination of wound drainage and malnutrition affect the outcome of joint arthroplasty. Clin Orthop Relat Res. 2008 Jun;466 (6):1368-71. Epub 2008 Apr 11.
256. Gherini S, Vaughn BK, Lombardi AV Jr, Mallory TH. Delayed wound healing and nutritional deficiencies after total hip arthroplasty. Clin Orthop Relat Res. 1993 Aug; (293):188-95.
257. Marín LA, Salido JA, López A, Silva A. Preoperative nutritional evaluation as a prognostic tool for wound healing. Acta Orthop Scand. 2002 Jan;73 (1):2-5.
258. Marchant MH Jr, Viens NA, Cook C, Vail TP, Bolognesi MP. The impact of glycemic control and diabetes mellitus on perioperative outcomes after total joint arthroplasty. J Bone Joint Surg Am. 2009 Jul;91 (7):1621-9.
259. Bolognesi MP, Marchant MH Jr, Viens NA, Cook C, Pietrobon R, Vail TP. The impact of diabetes on perioperative patient outcomes after total hip and total knee arthroplasty in the United States. J Arthroplasty. 2008 Sep;23 (6 Suppl 1):92-8.
260. American Diabetes Association. Diabetes basics. http://www.diabetes.org/ diabetes-basics/. Accessed 2012 Oct 2.
261. Rizvi AA, Chillag SA, Chillag KJ. Perioperative management of diabetes and hyperglycemia in patients undergoing orthopaedic surgery. J Am Acad Orthop Surg. 2010 Jul;18 (7):426-35.
262. Levetan CS, Passaro M, Jablonski K, Kass M, Ratner RE. Unrecognized diabetes among hospitalized patients. Diabetes Care. 1998 Feb;21 (2):246-9.
263. Browne JA, Cook C, Pietrobon R, Bethel MA, Richardson WJ. Diabetes and early postoperative outcomes following lumbar fusion. Spine (Phila Pa 1976). 2007 Sep 15;32 (20):2214-9.
264. Yang K, Yeo SJ, Lee BP, Lo NN. Total knee arthroplasty in diabetic patients: a study of 109 consecutive cases. J Arthroplasty. 2001 Jan;16 (1):102-6.
265. Papagelopoulos PJ, Idusuyi OB, Wallrichs SL, Morrey BF. Long term outcome and survivorship analysis of primary total knee arthroplasty in patients with diabetes mellitus. Clin Orthop Relat Res. 1996 Sep; (330):124-32.
266. Mraovic B, Hipszer BR, Epstein RH, Pequignot EC, Parvizi J, Joseph JI. Preadmission hyperglycemia is an independent risk factor for in-hospital symptomatic pulmonary embolism after major orthopedic surgery. J Arthroplasty. 2010 Jan;25 (1):64-70. Epub 2008 Dec 4.
267. Moghissi ES, Korytkowski MT, DiNardo M, Einhorn D, Hellman R, Hirsch IB, Inzucchi SE, Ismail-Beigi F, Kirkman MS, Umpierrez GE; American Association of Clinical Endocrinologists; American Diabetes Association. American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Endocr Pract. 2009 May-Jun;15 (4): 353-69.
268. Serna F, Mont MA, Krackow KA, Hungerford DS. Total knee arthroplasty in diabetic patients. Comparison to a matched control group. J Arthroplasty. 1994 Aug;9 (4):375-9.
269. Scanzello CR, Figgie MP, Nestor BJ, Goodman SM. Perioperative management of medications used in the treatment of rheumatoid arthritis. HSSJ. 206;2:141-7.
270. Jafri SM. Periprocedural thromboprophylaxis in patients receiving chronic anticoagulation therapy. Am Heart J. 2004 Jan;147 (1):3-15.
271. Dunn AS, Turpie AG. Perioperative management of patients receiving oral anticoagulants: a systematic review. Arch Intern Med. 2003 Apr 28;163 (8):901-8.
272. Heit JA. Perioperative management of the chronically anticoagulated patient. J Thromb Thrombolysis. 2001 Sep;12 (1):81-7.
273. David TS, Vrahas MS. Perioperative lower urinary tract infections and deep sepsis in patients undergoing total joint arthroplasty. J Am Acad Orthop Surg. 2000 Jan-Feb;8 (1):66-74.
274. Moucha CS, Clyburn T, Evans RP, Prokuski L. Modifiable risk factors for surgical site infection. J Bone Joint Surg Am. 2011 Feb 16;93 (4):398-404.
275. Rajamanickam A, Noor S, Usmani A. Should an asymptomatic patient with an abnormal urinalysis (bacteriuria or pyuria) be treated with antibiotics prior to major total joint replacement surgery? Cleve Clin J Med. 2007 Sep;74 Suppl 1:S17-8.
276. Ritter MA, Fechtman RW. Urinary tract sequelae: possible influence on joint infections following total joint replacement. Orthopedics. 1987 Mar;10 (3):467-9.